NCT00067015View on ClinicalTrials.gov

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

September 30, 2008

Conditions
Prostate Cancer
Interventions
DRUG

bicalutamide

DRUG

goserelin acetate

PROCEDURE

assessment of therapy complications

PROCEDURE

quality-of-life assessment

RADIATION

radiation therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00067015 - Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter